Premier Alternatives

Sudeep Pharma (BOM: 544619)

Vadodara, India · Founded 1989 · Publicly Held

Sudeep Pharma Ltd is a technology led manufacturer of excipients and specialty ingredients for the pharmaceutical, food, and nutrition industries and is dedicated to contributing to the healthcare… Sudeep Pharma (BOM: 544619) is based in Vadodara, India and was founded in 1989. It is now publicly traded; this page covers its private-market history, where its last recorded valuation was $754 million (Nov 2025). It has raised $40.9 million.

Last price · $/share
—
Implied valuation
$754.0M
Total raised
$40.9M
Last round
—

Sudeep Pharma (BOM: 544619) key facts

  • Sudeep Pharma Ltd is a technology led manufacturer of excipients and specialty ingredients for the pharmaceutical, food, and nutrition industries and is dedicated to contributing to the healthcare…
  • Sudeep Pharma (BOM: 544619)’s last known valuation is $754.0M (Nov 2025).
  • It has raised $40.9M; the latest was IPO ($70.5M) in Nov 2025.
  • Notable investors include Motilal Oswal Mutual Fund, Nippon India Mutual Fund, Aditya Birla Sun Life AMC, Bandhan Mutual Fund, Edelweiss Mutual Fund — 12 tracked in total.
  • Status: Publicly Held.
Free account
More of Sudeep Pharma (BOM: 544619) with a free account
  • ·The complete investor list: 12 names
  • ·Watch Sudeep Pharma (BOM: 544619): the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Sudeep Pharma (BOM: 544619) funding rounds

No rounds on record

No funding rounds for Sudeep Pharma (BOM: 544619) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

Sudeep Pharma (BOM: 544619) valuation

Sudeep Pharma (BOM: 544619) is now publicly traded; this page covers its private-market history, where its last recorded valuation was $754 million (Nov 2025). Secondary trades, fund marks and rounds below are the private-market record; the listed share price is not tracked here.

Sudeep Pharma (BOM: 544619) investors

12 investors are on record for Sudeep Pharma (BOM: 544619), including Motilal Oswal Mutual Fund, Nippon India Mutual Fund, Aditya Birla Sun Life AMC and Bandhan Mutual Fund.

About Sudeep Pharma (BOM: 544619)

Sudeep Pharma Ltd is a technology led manufacturer of excipients and specialty ingredients for the pharmaceutical, food, and nutrition industries and is dedicated to contributing to the healthcare ecosystem. The company operates in two business verticals: Pharmaceutical, food, and nutrition. It focuses on providing refined, mineral-based single ingredients essential to the pharmaceutical, food, and nutrition industries and Specialty ingredients: It pertains manufacturing of specialty ingredients using advance technology solutions. The maximum revenue is generated from the Pharmaceutical, food, and nutrition segment. Geographically, it has presence in the United States, South America, Europe, the Middle East, Africa, and Asia-Pacific.

Sector
Materials and Resources
HQ
Vadodara, India
Founded
1989
Employees
740
Ownership
Publicly Held

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.

Valuation on record
$754.0M

Sudeep Pharma (BOM: 544619)’s last known valuation, Nov 2025. A PrivateMarketView mark is published once fund marks, secondary prints or a priced round let us confirm it.